Kevin Hollevoet is an accomplished professional with extensive experience in research and development within the biotechnology and pharmaceutical sectors. Serving as R&D Program Manager at AbolerIS Pharma from November 2020 to January 2023, Kevin has a strong background in molecular biology, immunology, and drug discovery, having held various roles such as Postdoctoral Researcher at the National Cancer Institute and Program Director at General Inception. With experience in project management and entrepreneurship, including current positions as Project Manager at Commit Biologics and CEO & Co-founder at Hemastatx, Kevin also contributes to the academic community as an Associate Editor for the Journal of Translational Medicine. Educational credentials include a Bachelor and Master in Bioscience Engineering, an Executive Development Programme in Business Administration, and a Master's in Biotechnology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices